Health and FitnessHealth and Fitness
Tue, February 22, 2011
[ Tue, Feb 22nd 2011 ] - Market Wire
Additional Gold Tenements
[ Tue, Feb 22nd 2011 ] - Market Wire
00 P.M. EST
[ Tue, Feb 22nd 2011 ] - Market Wire
Rainy Day Accounts Run Dry
[ Tue, Feb 22nd 2011 ] - Market Wire
PROTOX APPOINTS NEW DIRECTORS

SuperGen to Announce 2010 Fourth Quarter and Year-End Financial Results on February 28, 2011


Published on 2011-02-22 03:20:40 - Market Wire
  Print publication without navigation


DUBLIN, Calif.--([ BUSINESS WIRE ])--SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to discovery and development of novel cancer therapies, announced that it will release its 2010 fourth quarter and fiscal year-end results on Monday, February 28, 2011. SuperGen's management team will provide details of the Company's financial results, and provide financial guidance for fiscal year 2011.

A press release will be issued following the close of the market on February 28th. The Company will host a webcast conference call to discuss the results at 4:30 p.m. ET. A live webcast of the call will be available in the Investor Events section of the Company's Web site at [ www.supergen.com ]. A webcast replay of the live conference call will be available shortly following the event. Alternatively, you may access a replay of the conference call by dialing (800) 642-1687 (domestic) and (706) 645-9291 (international); replay passcode number is 46514688. The webcast replay and conference call replay will be available for 30 days.

About SuperGen

SuperGen is a pharmaceutical company dedicated to discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit [ http://www.supergen.com ].